Immune-Mediated Adverse Effects of Checkpoint Inhibitors: A Clinical Experience

[1] Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64,93–101. KhanS GerberDE Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review Semin Cancer Biol 2020 64 93 101 10.1016/j.semcancer.2019.06.012698044431330185 Search in Google Scholar

[2] Wang PF, Chen Y, Song SY et al. Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis. Front Pharmacol. 2017;8,730. WangPF ChenY SongSY Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: A meta-analysis Front Pharmacol 2017 8 730 10.3389/fphar.2017.00730565153029093678 Search in Google Scholar